Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Infiltrating the Disc: Mast Cells & Back Pain

Lara C. Pullen, PhD  |  Issue: December 2017  |  November 6, 2017

Mast cells play an important role in the pathogenesis of degenerative musculoskeletal diseases and chronic pain conditions. Recent work has revealed that mast cells perform a critical function in the pathophysiology of osteoarthritis. Now, scientists have turned their attention to the role of mast cells in low back pain.

Researchers looked specifically at the intervertebral disc, which contains three integrated structures: the inner gelatinous nucleus pulposus (NP), the outer lamellar annulus fibrosus (AF) and the cartilaginous endplates (EP) that connect the invertebral discs to the vertebral bodies. A healthy intervertebral disc is considered immune privileged, and the disc—in particular the AF—acts as a physical and biochemical barrier to inflammation and immune cell infiltration. However, during aging, degeneration and/or injury, mast cells can enter the intervertebral disc. Although scientists have documented the presence of mast cells in painful discs, the role of mast cells in low back pain and intervertebral disc degeneration is still not well understood.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Recent research published online on Oct. 2 in Scientific Reports revealed that mast cells can infiltrate intervertebral disc cells and play a key role in their degeneration.1 The investigators designed their study to better understand the presence and role of mast cells within the intervertebral disc. Matthew G. Wiet, a medical student at Ohio State University, Columbus, and colleagues found that not only can mast cells affect the function of intervertebral disc cells, but intervertebral disc cells can also affect the function of mast cells.

“To our knowledge, this is the first study to explicitly explore the presence and function of mast cells in the intervertebral disc,” write the authors in the conclusion of their paper. “Here we demonstrated that mast cells are present in the painful [intervertebral disc] and that they likely play a key role in degeneration of the [disc]. We provide evidence that mast cells are able to 1) stimulate an inflammatory and catabolic phenotype in [intervertebral disc] cells specifically NP and EP cells, and vice versa, and 2) that healthy annulus fibrosus cells can inhibit activation of mast cells and a pro-angiogenic phenotype in these cells.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators used immunohistochemistry and 3D in vitro cell culture methods to characterize mast cell–intervertebral disc cell interactions. They began their work by using immunohistochemistry staining to investigate the presence of mast cell-specific markers within the human intervertebral disc. They examined painful intervertebral discs that had been surgically removed from patients and compared them with cadaveric intervertebral discs. Study limitation: The researchers assumed the cadaveric discs came from individuals who had died without back pain because the discs were intact upon the patient’s death. The researchers did not indicate that any efforts were made to determine whether the individuals had actually been living with pain prior to their deaths. This flaw appears to be reflected in the data: 19.3% of cadaveric samples had mast cells.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Back painintervertebral disclow back painmast cellOsteoarthritis

Related Articles

    2015 ACR/ARHP Annual Meeting: Cellular Triggers in Inflammatory Disease

    April 14, 2016

    SAN FRANCISCO—What factors help determine whether or not inflammation resolves, leading to healing, or becomes chronic, leading to disease and tissue destruction? A number of important cells, including toll-like receptors, mast cells, anti-citrullinated protein antibodies, complement and interferon, all play their own role in this process. By understanding how they act in innate and adaptive…

    Meet the Lumbar Spinal Stenosis Challenge

    August 1, 2007

    Limited evidence and diagnostic options make this increasing condition difficult to treat

    Acute Microcrystalline Arthropathy Masquerades as Infectious Discitis

    June 17, 2019

    Monosodium urate (MSU) crystal deposition commonly occurs within the distal appendicular skeleton. The peripheral nature of gout is a hallmark feature described in the ACR and the European League Against Rheumatism (EULAR) clinical practice guidelines.1 In this article, we report a rare presentation of a common disease: a case of axial gouty arthropathy masquerading as…

    Lactoferricin’s Role in Preventing Disc Degeneration

    September 16, 2013

    The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences